About the
Awards

COSA offers the Best of the Best Awards at each of the Best of the Best Oral and Poster Sessions at the COSA Annual Scientific Meeting (ASM). Independent adjudicators award the prizes at the session based on the content, the importance of the research, and the quality of the presentation. The Best of the Best Oral Awards are for $1,000 in each session. Best of the Best Poster Awards are for $500 in each session.

Aerieal_audience

To be eligible for an award you must:

2021 Best of the Best Oral Presentation Award recipients

Mitchell S von Itzstein
Clinical and biological correlates of immune-related adverse events

Yada Kanjanapan
COVID-19 vaccination in patients with solid tumours: development of an Australian position statement

Sylvia Eugene Dit Rochesson 
Exploring healthcare providers’ perspectives on psychosexual healthcare for LGBTIQ+ cancer survivors: A mixed-methods study

Sarah Badaoui
Association between patient-reported outcomes and survival in patients initiating first-line atezolizumab combination therapy for advanced non-small cell lung cancer (NSCLC)

Kate Dunn
Variability across Victorian hospitals in the care of patients with metastatic colorectal cancer: using comprehensive registry data to explore potential quality indicators

Prachi Bhave
Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)

Carolyn Mazariego
Priority Recommendations for the Implementation of Patient Reported Outcomes in Clinical Cancer Care: A Delphi study

Kate White
Evaluating a shared care pathway intervention to reduce chemotherapy outpatients' unplanned presentations to hospital: A randomised controlled trial (RCT)

Claire Cooper
Development of Psycho-oncology Telehealth Recommendations

Lisa Beatty
Finding My Way in the real world: how do outcomes of a digital psycho-oncology program compare from clinical trial to implementation?

2021 Best of the Best Rapid Fire Poster Oral Presentation Award recipients

Jessica McKie
The use of neoadjuvant systemic therapy in early breast cancer as a guide to locoregional therapies: A single institution review

Lara Edbrooke
Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer

 Eva Yuen
The moderating role of social connectedness on the relationship between cancer caregiver burden and psychological outcomes

Fanny Franchini
Budget impact modelling for listing new cancer treatments in different cancer stages using real-world data

Sarah Lewis
Improved survival predicted by irAEs on 18F-FDG-PET in response to PD-1 antibody therapy in metastatic melanoma

Jon Emery
The CRISP Trial: a randomised controlled trial of a risk assessment and decision support tool for risk-stratified colorectal cancer screening in primary care